DEA to Convene Hearing on Two Little-Known ‘Phenethylamine Hallucinogens’

April 12, 2024

Clairvoyant Expects to Bring Psilocybin Treatment to Market By 2025

April 5, 2024

Healing War Wounds: Stanford Explores Ibogaine’s Potential for Brain Injuries

April 2, 2024

4th Annual Psychedelic Therapeutics & Drug Development Conference

March 24, 2024

At-Home Ketamine Therapy: Breakthrough or Breakdown?

March 21, 2024

Ketamine: Addiction Treatment or Enabler?

March 12, 2024